Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience

Journal of B.U.ON.

Volumn 11, Issue 4, 2006, Pages 433-438

  Avramova, Boryana ^a   Jordanova, M ^a   Michailov, G ^b   Konstantinov, D ^a   Christosova, I ^a   Bobev, Dr ^a  

^a Specialized Hospital for Pediatric Oncohematology and Bone Marrow Transplantation   (Bulgaria)

^b National Center of Hematology and Transfusion Medicine   (Bulgaria)

Author keywords

Autologous transplantation; High dose chemotherapy; Relapse; Resistance; Solid tumors; Stem cells

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; THIOTEPA; ANTINEOPLASTIC AGENT; MYELOABLATIVE AGENT;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD TOXICITY; BREAST CANCER; BULGARIA; CANCER REGRESSION; CANCER RELAPSE; CD34 SELECTION; CHILD; CLINICAL ARTICLE; DIARRHEA; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG FEVER; DRUG MEGADOSE; EWING SARCOMA; FEMALE; FEVER; FOLLOW UP; GERM CELL TUMOR; GRAFT FAILURE; HUMAN; LUNG BLASTOMA; LYMPHOEPITHELIOMA; MALE; MUCOSA INFLAMMATION; MYELOABLATIVE CONDITIONING; NEUROBLASTOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RHABDOMYOSARCOMA; SOLID TUMOR; TREATMENT OUTCOME; ADOLESCENT; AUTOTRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; REMISSION; RETROSPECTIVE STUDY; SALVAGE THERAPY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BULGARIA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 33947528402     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Horowitz MM, Rowlings PA. An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol 1997; 4: 395-400.
2. Carnecale-Schianca F, Ricciardi A, Capaldi A et al. Allogeneic hemopoietic stem cell transplantation in solid tumors. Transplant Proc 2005; 37: 2664-2666.
3. EBMT survey on transplant activity 2004 and 2005.
4. Robinson LL. General principles of epidemiology of childhood cancer. In: Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (3rd edn). Philadelphia: Lippincott-Raven Publ, 1997, pp 1-10.
5. Kung FH, Pratt CB, Vega RA et al. Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II study. Cancer 1993; 71: 1898-1903.
6. Samaniego F, Bosl G, Geller N, Penenberg D,Golbey R. Identification of prognostic variables in patients with germ cell tumor within the poor risk subgroup. Proc Am Soc Clin Oncol 1988; 7: 132 (abstr).
7. Birch R, Wiliams S, Cone A et al. Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 1986; 4: 400-407.
8. Hara I, Miyake H, Yamada Y et al. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience. Anticancer Drugs 2006;17: 1057-1066.
9. Shigemura K, Tanaka H, Hara I et al. Clinical study for management of supportive treatment for high-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) for intractable testicular tumor. Hinyokika Kiyo 2006; 52: 531-536.
10. Muller AM, Ihorst G, Waller CF et al. Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor. Biol Blood Marrow Transplant 2006; 12: 355-365.
11. Broun E, Nichols C, Kneebone P et al. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 1992; 117: 124-128.
12. Kushner BH, Cheung NK. Neuroblastoma. Pediatr Ann 1988; 17: 269-276 and 278.
13. Stram DO, Matthay KK, O'Leary M et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: A report of two concurrent Children's Cancer Group Studies. J Clin Oncol 1996; 14: 2413-2426.
14. Matthay KK, Seeger RC, Reynolds CP et al. Allogeneic vs autologous purged bone marrow transplantation for neuroblastoma: A report from the Children's Cancer Group. J Clin Oncot 1994; 12: 2382-2389.
15. Matthay KK, Perez C, Seeger RC et al. Improved event free survival for autologous bone marrow transplantation vs. chemotherapy in neuroblastoma: A phase III randomized Children's Cancer Group study. Proc Am Soc Clin Oncol 1998; 17: 2018 (abstr).
16. Burdach S, Jurgens H. High-dose chemotherapy (HDC) in the Ewing's family of tumors (EFT). Crit Rev Oncol Hematol 2002; 41: 169-189.
17. Pinkerton CR, Bataillard A, Guillo S et al. Treatment strategies for metastatic Ewing's sarcoma. Eur J Cancer 2001; 37: 1338-1344.
18. Ladenstein R, Gadner H, Hartmann O et al. The impact of megatherapy followed by stem cell reinfusion in Ewing's sarcoma patients with residual disease. Bone Marrow Transplant 1997; 19: S86.
19. Ladenstein R, Lasset C, Pinkerton R et al. Impact of megatherapy in children with high risks Ewing's tumors in complete remission. A report from the EBMT Solid Tumor Registry. Bone Marrow Transplant 1995; 15: 697-705.
20. Carli M, Colombatti R, Oberlin O et al. High-dose melphalan with autologous stem cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol 1999; 17: 2796-2803.
21. Pedrazzoli P, Ferrante P, Kulekci A et al. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999. Bone Marrow Transplant 2003; 32: 489-494.
22. Martino M, Morabito F, Console G et al. Differences in transplant-related complications between hematologic malignancies and solid tumors receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Tumori 2003; 89: 385-390.